Kobinger W, Pichler L
J Cardiovasc Pharmacol. 1982;4 Suppl 1:S81-5. doi: 10.1097/00005344-198200041-00017.
A great deal of experimental observations at alpha-adrenoceptors may be explained if two points are considered: (1) the alpha 1-/adrenoceptor ratio (selectivity ratio) of a given drug and (2) the ratio of alpha 1-/adrenoceptors in the target organ or tissue. The alpha 1-/alpha 2-selectivity ratio for 10 agonists was determined in pithed rats by their hypertensive effect in the presence or absence of the antagonists rauwolscine or prazosin, respectively. Treatment with a beta-blocking agent made it possible to test drugs with additional beta-adrenergic potencies (phenylethylamines). Methoxamine exerted the highest alpha 1-/alpha 2-selectivity ratio, the azepine derivative B-HT 920 the lowest ratio, i.e., the highest selectivity for alpha 2-adrenoceptors. Using the two selective agonists methoxamine and B-HT 920, respectively, the alpha 1-/alpha 2-adrenoceptor ratio (importance) in several target systems was estimated (determination of equieffective doses). Results indicated the prevalence of alpha 1-adrenoceptors in the nictitating membrane, and the equal importance of both subtypes at peripheral postsynaptic vascular sites in rats, as well as in cats. At presynaptic sites (cardiac nerve, rats), alpha 2-adrenoceptors are prevalent. A comparison of equieffective doses of B-HT 920 and clonidine in cats indicated the alpha 2-nature of the central adrenoceptors which mediate hypotension.
如果考虑两点,那么许多关于α-肾上腺素能受体的实验观察结果都可以得到解释:(1)给定药物的α1/α2-肾上腺素能受体比率(选择性比率),以及(2)靶器官或组织中α1/α2-肾上腺素能受体的比率。在去大脑大鼠中,分别通过在存在或不存在拮抗剂萝芙木碱或哌唑嗪的情况下观察其升压作用,测定了10种激动剂的α1/α2-选择性比率。使用β-阻滞剂进行治疗,使得能够测试具有额外β-肾上腺素能活性的药物(苯乙胺类)。甲氧明的α1/α2-选择性比率最高,氮杂环庚烷衍生物B-HT 920的比率最低,即对α2-肾上腺素能受体的选择性最高。分别使用两种选择性激动剂甲氧明和B-HT 920,估计了几个靶系统中的α1/α2-肾上腺素能受体比率(重要性)(测定等效剂量)。结果表明,在大鼠和猫的瞬膜中α1-肾上腺素能受体占优势,在大鼠和猫的外周突触后血管部位,两种亚型的重要性相当。在突触前部位(大鼠的心神经)α2-肾上腺素能受体占优势。比较猫中B-HT 920和可乐定的等效剂量表明,介导低血压的中枢肾上腺素能受体具有α2-特性。